Role of Iron Metabolism in Obesity, Type 2 Diabetes Mellitus, Atherosclerotic Cardiovascular Disease, and Metabolic Dysfunction-Associated Steatotic Liver Disease – A Narrative Review
Chronicle of Diabetes Research and Practice · 2026
DOI: 10.4103/cdrp.cdrp_18_25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chronicle of Diabetes Research and Practice, 2026. Verfasst von Vinod K. Abichandani. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Diabetes mellitus
Abstract (Originalsprache)
Iron is a vital micronutrient for numerous physiological processes, including oxygen transport, DNA synthesis, electron transport in humans, and energy production. Dysregulation of iron metabolism plays a role in various metabolic disorders such as obesity, type 2 diabetes mellitus, atherosclerotic cardiovascular disease, and metabolic dysfunction-associated steatotic liver disease. This narrative review explores the interconnected pathways linking iron metabolism to these conditions, emphasizing the roles of iron overload, deficiency, and altered distribution. Understanding these relationships provides a foundation for therapeutic strategies targeting iron homeostasis to mitigate disease progression and complications.
Zitieren
APA
Abichandani, V. K. (2026). Role of Iron Metabolism in Obesity, Type 2 Diabetes Mellitus, Atherosclerotic Cardiovascular Disease, and Metabolic Dysfunction-Associated Steatotic Liver Disease – A Narrative Review. Chronicle of Diabetes Research and Practice. https://doi.org/10.4103/cdrp.cdrp_18_25
Vancouver
Abichandani VK. Role of Iron Metabolism in Obesity, Type 2 Diabetes Mellitus, Atherosclerotic Cardiovascular Disease, and Metabolic Dysfunction-Associated Steatotic Liver Disease – A Narrative Review. Chronicle of Diabetes Research and Practice. 2026. doi:10.4103/cdrp.cdrp_18_25
BibTeX
@article{Abichandani2026,
author = {Abichandani, Vinod K.},
title = {Role of Iron Metabolism in Obesity, Type 2 Diabetes Mellitus, Atherosclerotic Cardiovascular Disease, and Metabolic Dysfunction-Associated Steatotic Liver Disease – A Narrative Review},
journal = {Chronicle of Diabetes Research and Practice},
year = {2026},
doi = {10.4103/cdrp.cdrp_18_25}
}
EUVIMED